abstract：BACKGROUND:The use of chromium-containing dietary supplements is widespread among patients with type 2 diabetes. Chromium's effects in patients at high risk for developing diabetes, especially those with metabolic syndrome, is unknown. The objective of this study was to determine the effects of chromium picolinate (CrP...

journal_title：Metabolic syndrome and related disorders

authors： Iqbal N,Cardillo S,Volger S,Bloedon LT,Anderson RA,Boston R,Szapary PO

更新日期：2009-04-01 00:00:00

abstract：BACKGROUND:Metabolic syndrome occurs commonly in the United States. The purpose of this study was to measure the prevalence of metabolic syndrome among American Indian and Alaska Native people. METHODS:We measured the prevalence rates of metabolic syndrome, as defined by the National Cholesterol Education Program, amo...

journal_title：Metabolic syndrome and related disorders

authors： Schumacher C,Ferucci ED,Lanier AP,Slattery ML,Schraer CD,Raymer TW,Dillard D,Murtaugh MA,Tom-Orme L

更新日期：2008-12-01 00:00:00

abstract：BACKGROUND:Previous reports indicate that both distribution and amount of body fat confers susceptibility to metabolic syndrome. However, the relative contributions of these two different parameters of body fat to the various components of the metabolic syndrome have not been well defined. METHODS:Dual-energy X-ray ab...

journal_title：Metabolic syndrome and related disorders

authors： Grundy SM,Adams-Huet B,Vega GL

更新日期：2008-12-01 00:00:00

abstract：BACKGROUND:Metabolic syndrome increases the risk of diabetes and cardiovascular disease. Yoga improves some metabolic parameters, but it has not been studied in persons with metabolic syndrome. We conducted a randomized controlled pilot trial to determine whether a restorative yoga intervention was feasible and accepta...

journal_title：Metabolic syndrome and related disorders

authors： Cohen BE,Chang AA,Grady D,Kanaya AM

更新日期：2008-09-01 00:00:00

abstract：:Over the past two decades, there has been a striking increase in the number of people with metabolic syndrome. The prevalence of metabolic syndrome varies due to lack of an internationally agreed upon definition. Considering the increased cardiovascular risk among Asian people, a lower cutoff for waist circumference i...

journal_title：Metabolic syndrome and related disorders

authors： Basit A,Shera AS

更新日期：2008-09-01 00:00:00

abstract：:Nonalcoholic fatty liver disease (NAFLD) is a major form of chronic liver disease in adults and children. It is one of the consequences of the current obesity epidemic, and can progress to nonalcoholic steatohepatitis (NASH), characterized by steatosis, inflammation, and progressive fibrosis, ultimately leading to cir...

journal_title：Metabolic syndrome and related disorders

authors： Jiang J,Torok N

更新日期：2008-03-01 00:00:00

abstract：BACKGROUND:We compared the lipid-altering effects of ezetimibe/simvastatin (EZE/SIMVA) co-administered with fenofibrate (FENO) in mixed hyperlipidemic patients with (MetS) versus those without MetS. METHODS:A total of 611 patients, 20 to 79 years old, with LDL-C 130-220 mg/dL (100-180 mg/dL for patients with type 2 di...

journal_title：Metabolic syndrome and related disorders

authors： Gil-Extremera B,Mendez G,Zakson M,Meehan A,Shah A,Lin J,Mitchel Y

更新日期：2007-12-01 00:00:00

abstract：BACKGROUND:The purpose of this study was to examine effect modifiers of the relationship between family history of diabetes, a proxy for genetic predisposition, and the metabolic syndrome. METHODS:Subjects were a cross-sectional sample of 205 Mexican-Americans patients of the San Ysidro Health Center in San Diego Coun...

journal_title：Metabolic syndrome and related disorders

authors： Nelson T,Perez A,Alcaraz J,Talavera G,McCarthy JJ

更新日期：2007-09-01 00:00:00

abstract：BACKGROUND:The fetal origins hypothesis indicates that morphometric evidence of fetal nutritional deprivation is predictive of excessive weight gain/obesity, insulin resistance, and cardiovascular disease after birth. However, it is unclear whether these effects are present in offspring with "normal" birth weights in c...

journal_title：Metabolic syndrome and related disorders

authors： Clapp Iii JF,Lopez B

更新日期：2007-06-01 00:00:00

abstract：BACKGROUND:The combination of ezetimibe and simvastatin (EZE/SIMVA) inhibits intestinal absorption and hepatic synthesis of cholesterol, providing significantly greater LDL-C-lowering compared to either drug alone. We examined the efficacy and safety of EZE/SIMVAin hypercholesterolemic patients with metabolic syndrome ...

journal_title：Metabolic syndrome and related disorders

authors： Feldman T,Ose L,Shah A,Zakson M,Meehan A,Johnson-Levonas AO,Maccubbin D,Tribble DL,Veltri E,Mitchel Y

更新日期：2007-04-01 00:00:00

abstract：:A 20-year-old woman with epilepsy had resolution of features of polycystic ovary syndrome on discontinuing valproic acid; they reappeared with the newer antiepileptic divalproex sodium. ...

journal_title：Metabolic syndrome and related disorders

authors： Sridhar GR,Nagamani G

更新日期：2006-10-01 00:00:00

abstract：:Omega-3s are found in oily fish. We have drastically reduced our intake of fish during the last century. Many of us therefore suffer from a deficiency of omega-3s, which has consequences for health. In this review, we focus on structure-functional relationships and the relation of omega-3s to the metabolic syndrome, i...

journal_title：Metabolic syndrome and related disorders

authors： Saldeen P,Saldeen T

更新日期：2006-07-01 00:00:00

abstract：:The metabolic syndrome increases the risk of atherothrombotic cardiovascular disease (CVD) and diabetes. In turn, diabetes promotes the development of atheroma and is regarded as a coronary heart disease risk equivalent. A multifactorial therapeutic strategy is advocated for patients with the metabolic syndrome to imp...

journal_title：Metabolic syndrome and related disorders

authors： Krentz AJ

更新日期：2006-01-01 00:00:00

abstract：BACKGROUND:The aim of this study was to study (1) weight gain in type 2 diabetics with different treatment modalities and (2) relationship of weight gain with stable adult weight. METHODS:A study of 469 type 2 diabetics on regular follow-up was undertaken to determine the effect of modality of therapy on patient's wei...

journal_title：Metabolic syndrome and related disorders

authors： Chandalia HB,Lamba PS,Chandalia SH,Singh DK,Modi SV,Shaikh SA

更新日期：2005-07-01 00:00:00

abstract：BACKGROUND:In the fed state, the glucose disposal action of insulin can be attributed in approximately equal part to the direct action of insulin and to a hepatic insulin sensitizing substance (HISS) that acts selectively on skeletal muscle. HISS action is absent in the 24-hour fasted state. The objective of this study...

journal_title：Metabolic syndrome and related disorders

authors： Lautt WW,Legare DJ,Reid MA,Sadri P,Ting JW,Prieditis H

更新日期：2005-01-01 00:00:00

abstract：:The metabolic syndrome (MS) is a clustering of cardiovascular risk factors, with insulin resistance as a major feature. This syndrome has been variously defined, but generally consists of 3 or more of the following components: hyperglycemia, hypertension, hypertriglyceridemia, low HDL, and increased abdominal circumfe...

journal_title：Metabolic syndrome and related disorders

authors： Sutherland JP,McKinley B,Eckel RH

更新日期：2004-06-01 00:00:00

abstract：:The perspective presented here is a working hypothesis suggesting a new paradigm for insulin resistance where, analogous to the cause of type 1 diabetes being attributed to lack of insulin, type 2 diabetes is due to lack of action of a hepatic insulin sensitizing substance (HISS). In both cases, the major metabolic dy...

journal_title：Metabolic syndrome and related disorders

authors： Lautt WW

更新日期：2003-12-01 00:00:00